> top > docs > PMC:7029759 > spans > 22122-22406 > annotations

PMC:7029759 / 22122-22406 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
512 174-183 Species denotes 2019-nCoV Tax:2697049
516 14-18 Disease denotes SARS MESH:D045169
517 89-93 Disease denotes SARS MESH:D045169
518 154-163 Disease denotes infection MESH:D007239

LitCovid-PMC-OGER-BB

Id Subject Object Predicate Lexical cue
T327 14-18 SP_10 denotes SARS
T326 66-72 UBERON:0002405;GO:0006955 denotes immune
T325 73-81 GO:0006955 denotes response
T324 89-93 SP_10 denotes SARS
T323 174-183 SP_7 denotes 2019-nCoV
T322 237-243 UBERON:0002405;GO:0006955 denotes immune
T321 244-252 GO:0006955 denotes response
T320 262-269 NCBITaxon:10239 denotes viruses

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T126 37-41 Body_part denotes body http://purl.org/sig/ont/fma/fma256135
T127 94-101 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T64 14-18 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T65 89-93 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T66 154-163 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T191 262-269 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes viruses

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T83 94-101 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080

LitCovid-PD-GO-BP

Id Subject Object Predicate Lexical cue
T14 66-81 http://purl.obolibrary.org/obo/GO_0006955 denotes immune response
T15 237-252 http://purl.obolibrary.org/obo/GO_0006955 denotes immune response

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T144 0-284 Sentence denotes Regarding the SARS RBD strategy, the body would likely develop an immune response to the SARS protein eventually, although the key intervention period of infection to combat 2019-nCoV would fall under this window of time, where after an immune response for both viruses would develop.